局部晚期三阴性乳腺癌的临床试验
总计2210个结果
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.终止三阴性乳腺癌 | IV 期乳腺癌 | 三阴性乳腺癌 | 复发性乳腺癌 | 人类表皮生长因子 2 阴性乳腺癌 | Estrogen Receptor Negative Breast Cancer美国
-
Mayo ClinicNational Cancer Institute (NCI)完全的骨转移性恶性肿瘤 | 三阴性乳腺癌 | IV 期乳腺癌 AJCC v6 和 v7美国
-
National Cancer Institute (NCI)终止三阴性乳腺癌 | IV 期乳腺癌 AJCC v6 和 v7 | III 期乳腺癌 AJCC v7 | IIIA 期乳腺癌 AJCC v7 | IIIB 期乳腺癌 AJCC v7 | IIIC 期乳腺癌 AJCC v7 | 晚期乳腺癌 | 转移性乳腺癌美国
-
Abramson Cancer Center at Penn Medicine招聘中
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLC; Gilead Sciences招聘中
-
Dompé Farmaceutici S.p.APRA Health Sciences完全的
-
Providence Health & ServicesInhibrx, Inc.尚未招聘
-
Institut CurieRoche Pharma AG; National Research Agency, France尚未招聘
-
AstraZenecaSWOG Clinical Trials Partnerships; Daiichi Sankyo招聘中乳腺癌美国, 中国, 丹麦, 英国, 大韩民国, 加拿大, 德国, 意大利, 比利时, 西班牙, 日本, 法国, 台湾, 希腊, 巴西, 瑞典, 波多黎各
-
West China HospitalJiangsu HengRui Medicine Co., Ltd.招聘中
-
wang shusen招聘中
-
Cantargia ABSpanish Breast Cancer Research Group招聘中
-
Massachusetts General HospitalUniversity of Pennsylvania; Duke University; Sibley Memorial Hospital招聘中
-
The First Affiliated Hospital with Nanjing Medical...尚未招聘
-
Peking Union Medical College Hospital招聘中
-
Shengjing HospitalThe People's Hospital of Liaoning Province; Liaoning Tumor Hospital & Institute招聘中
-
Eileen ConnollyMerck Sharp & Dohme LLC招聘中
-
Washington University School of MedicineBristol-Myers Squibb主动,不招人
-
Fundacion OncosurPfizer; Apices Soluciones S.L.; Pierre Fabre Ibérica, S.A.完全的
-
ImmunityBio, Inc.主动,不招人
-
Novartis Pharmaceuticals撤销
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLC完全的
-
Canadian Cancer Trials GroupUniversity Health Network, Toronto; AstraZeneca主动,不招人
-
The Netherlands Cancer InstituteBristol-Myers Squibb主动,不招人
-
Georgetown UniversityBristol-Myers Squibb主动,不招人
-
University of Wisconsin, MadisonThe V Foundation for Cancer Research终止
-
Cedars-Sinai Medical CenterAstraZeneca撤销
-
ImmunityBio, Inc.撤销